# Cytogen

> Cytogen is a VC fund in Seoul backing Biotechnology, Pharmaceutical and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 2
- Last investment: Oct 2021
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://cytogenlab.com 

Cytogen is a VC fund in Seoul focused on Biotechnology and Pharmaceutical. Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment systems for cancer diagnosis and treatment in South Korea. It offers Smart Biopsy, an automated CTC enrichment system from blood sample; and cell isolators, IF stainers, cell image analyzers, time laps analyzers, isolation kits, and culture kits. The company was founded in2010 and is headquartered in Seoul, South Korea.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Medical | 1 | 50% |
| Life Science | 1 | 50% |
| Clinical Trials | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series C | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Wellmarker Bio | Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer. | $11.8M | Series C | Oct 14, 2021 | http://www.wmbio.co/ |
| TSD Life Sciences | TSD Life Sciences is a bio company that provides clinical research services to defeat cancer through research and development. | $8.8M | Series A | Jun 16, 2021 | http://www.tsdls.co.kr |

2 of 2 investments shown.

## Co-investors
- [Boditech Med](https://shizune.co/investors/profile/boditech-med) — VC Fund, 1 deal together
- [eBEST](https://shizune.co/investors/profile/ebest-33b0) — VC Fund, 1 deal together
- [Elohim Partners](https://shizune.co/investors/profile/elohim-partners) — VC Fund, 1 deal together
- [GTG Capital Partners](https://shizune.co/investors/profile/gtg-capital-partners) — VC Fund, 1 deal together
- [IBK Capital](https://shizune.co/investors/profile/ibk-capital-951b) — VC Fund, 1 deal together
- [Industrial Bank of Korea](https://shizune.co/investors/profile/industrial-bank-of-korea) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Life Science VC Funds in South Korea](https://shizune.co/investors/life-science-vc-funds-south-korea)

## FAQ

### What does Cytogen invest in?

Cytogen invests primarily in Biotechnology, Pharmaceutical and Medical startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cytogen last invest?

The most recent investment recorded for Cytogen closed in Oct 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co